Related Experiment Video

Updated: May 24, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

[The new ESC guidelines for non-ST-elevation acute coronary syndromes: one direction, many ways, clinical wisdom]

Stefano Savonitto1, Matteo Azzarone, Rita Salsi

  • 1S.C. di Cardiologia, Arcispedale S. Maria Nuova, Reggio Emilia. stefano.savonitto@asmn.re.it

Giornale Italiano Di Cardiologia (2006)
|March 8, 2012
PubMed

Insights

The 2011 ESC guidelines emphasize risk stratification for non-ST-segment elevation acute coronary syndromes (NSTE-ACS). High-risk patients benefit most from aggressive treatment, including early angiography.

Area of Science:

  • Cardiology
  • Clinical Guidelines
  • Acute Coronary Syndromes

Context:

  • The 2011 European Society of Cardiology (ESC) guidelines for non-ST-segment elevation acute coronary syndromes (NSTE-ACS) are discussed.
  • Current management strategies are based on risk stratification to guide treatment intensity.

Purpose:

  • To summarize the key principles of the 2011 ESC guidelines for NSTE-ACS.
  • To highlight the importance of risk stratification in determining the optimal management approach.

Summary:

  • The guidelines advocate an aggressive pharmacointerventional strategy for high-risk NSTE-ACS patients, correlating higher ischemic event risk with greater treatment benefit.
  • This approach influences decisions regarding the timing of angiography and revascularization, as well as the selection of pharmacological therapies.
  • Clinical judgment is crucial for managing complex and frail patients, balancing the efficacy and safety of various treatment options.

Impact:

  • The guidelines suggest extending the established networks for ST-elevation myocardial infarction (STEMI) primary percutaneous coronary intervention to NSTE-ACS patients.
  • This aims to facilitate timely coronary angiography (within 24 hours) for high-risk NSTE-ACS individuals, potentially improving outcomes.
  • The principles underscore a shift towards more proactive and individualized management of NSTE-ACS based on comprehensive risk assessment.

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...